Skip to main content
. 2002 Jul;161(1):183–193. doi: 10.1016/s0002-9440(10)64170-3

Figure 2.

Figure 2.

TGF-β1 HepG2-treated cells acquire migration on Ln-5. Treated HepG2 cells (open bars) migrate on Ln-5 but untreated cells (filled bars) do not. This migration is further stimulated in a dose-dependent manner by exogenously added MMP-2, whereas untreated cells remain nonmigratory. Blotto is used as a negative control.